Silverfin false false 30/11/2025 30/11/2025 01/12/2024 The principal activity of the Company during the financial year was specialist medical practice activities. R W Fewkes 29/11/2022 T M A Roy 29/11/2022 14514526 2025-11-30 14514526 bus:Director1 2025-11-30 14514526 bus:Director2 2025-11-30 14514526 2024-11-30 14514526 core:CurrentFinancialInstruments 2025-11-30 14514526 core:CurrentFinancialInstruments 2024-11-30 14514526 2024-12-01 2025-11-30 14514526 bus:Micro-entities 2024-12-01 2025-11-30 14514526 bus:FilletedAccounts 2024-12-01 2025-11-30 14514526 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 14514526 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 14514526 bus:Director1 2024-12-01 2025-11-30 14514526 bus:Director2 2024-12-01 2025-11-30 14514526 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Company No: 14514526 (England and Wales)

# M.R.F. MEDICS LIMITED

### Unaudited Financial Statements
For the financial year ended 30 November 2025
Pages for filing with the registrar

M.R.F. MEDICS LIMITED

## UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 November 2025

Contents

M.R.F. MEDICS LIMITED

## BALANCE SHEET

As at 30 November 2025
M.R.F. MEDICS LIMITED

## BALANCE SHEET (continued)

For the financial year ended 30 November 2025

|  | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  | 2,282 |  | 2,489
Current assets |  | 57,969 |  | 46,137
Creditors: amounts falling due within one year |  | ( 4,995) |  | ( 4,742)
Net current assets |  | 52,974 |  | 41,395
Total assets less current liabilities |  | 55,256 |  | 43,884
Accruals and deferred income |  | ( 2,134) |  | ( 1,535)
Net assets |  | 53,122 |  | 42,349
Capital and reserves |  | 53,122 |  | 42,349

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of M.R.F. Medics Limited (registered number: 14514526) were approved and authorised for issue by the Board of Directors on 08 July 2026 and were signed on its behalf by:

T M A Roy Director |

M.R.F. MEDICS LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2025
M.R.F. MEDICS LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 November 2025

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 14514526). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the financial year, including directors | 2 |  | 2

#### 3. Directors’ benefits: advances, credit and guarantees

##### Advances

The directors loan account is repayable on demand and interest is charged on overdrawn balances exceeding £10,000 at the official HMRC rates.
At 1 December 2024, the balance owed by the directors was £6,309. During the year, £475 was advanced to the directors, and £6,784 was repaid by the directors. At 30 November 2025, the balance owed by the directors was nil.
At 1 December 2023, the balance owed by the directors was £8,301. During the year, £6,906 was advanced to the directors, and £8,898 was repaid by the directors. At 30 November 2024, the balance owed by the directors was £6,309.